FDA sought policy recommendations on mental health medical devices, including AI-enabled. After I reviewed submissions, one caught my attention. An AI Insider perspective.

Capricor Therapeutics faces high regulatory risks for its DMD therapy. Get expert analysis on trial data and FDA challenges.

Opinion: Researchers from the Oxford Internet Institute argue that lessons from social sciences can help us better assess the ...